The FDA wants to pull its approval of a drug. It’s not so easy.

The regulator says Tavneos was approved on the basis of manipulated study data. Should patients still have access to it?

KioskNews shows the publisher’s own headline, image, and summary — the full article always lives on their site, not ours.